Cart
sales@molnova.com
Teriflunomide(b)
CAS No. 163451-81-8
Teriflunomide(b) ( A 77-1726 )
Catalog No. M20895 CAS No. 163451-81-8
Teriflunomide is the principal active metabolite of leflunomide?an approved therapy for rheumatoid arthritis and?multiple sclerosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 41 | Get Quote |
|
| 50MG | 52 | Get Quote |
|
| 100MG | 81 | Get Quote |
|
| 500MG | 133 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTeriflunomide(b)
-
NoteResearch use only not for human use.
-
Brief DescriptionTeriflunomide is the principal active metabolite of leflunomide?an approved therapy for rheumatoid arthritis and?multiple sclerosis.
-
DescriptionTeriflunomide is the principal active metabolite of leflunomide?an approved therapy for rheumatoid arthritis and?multiple sclerosis.
-
SynonymsA 77-1726
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
Indicationmultiple sclerosis (MS)
Chemical Information
-
CAS Number163451-81-8
-
Formula Weight270.21
-
Molecular FormulaC12H9F3N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:26 mg/mL (96.22 mM)
-
SMILESC/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Paul O Oh . An update of teriflunomide for treatment of multiple sclerosis[J]. Therapeutics and Clinical Risk Management 2013:177-.
molnova catalog
related products
-
Lidocaine N-ethyl br...
Lidocaine N-ethyl bromide is a blocker of non-membrane-permeable,and Inhibits Acid-Induced Activation of Esophageal Nociceptive C Fiber Neurons.
-
Amaranth
Amaranth as a potential component of lifestyle modification to improve cardiovascular risk profiles by modifying cardiovascular risk factors such as cholesterol diabetes and hypertension.
-
TPEN
TPEN is a specific cell-permeable heavy metal chelator.
